1. Why Testosterone Matters—and Falls
Beginning around age 30, men and women lose about 1 % of circulating testosterone every year, leading to fatigue, visceral fat gain, and low libido. (Cleveland Clinic) Left unchecked, this decline accelerates metabolic syndrome and fractures.
2. Medical vs. Vanity: Who Actually Needs Therapy?
The Endocrine Society requires both (a) symptoms of androgen deficiency and (b) two separate morning total-T readings below the lab’s lower limit to diagnose hypogonadism. (Endocrine Society) GitelCare follows that guideline—and adds free-T, SHBG, estradiol, LH, FSH, PSA, CBC, CMP, and lipids before making any prescription decision.
3. Core Protocol Snapshot
| Compound | Standard Dose | Route / Needle | Frequency | Primary Goal |
|---|---|---|---|---|
| Testosterone cypionate | 120 mg | IM (27 G) | Weekly | Restore physiologic T (650–900 ng/dL) |
| HCG | 500 IU | SC (30 G) | 3× week | Preserve fertility & testicular volume |
| CJC-1295 + Ipamorelin | 300 µg | SC | 5 days on / 2 off | Boost endogenous GH & recovery |
Doses are individualized after baseline labs, body-comp scan, and symptom score.
4. Why We Stack HCG
Concomitant HCG maintains intratesticular testosterone, sustaining spermatogenesis even during TRT—critical for men who still want children. (PMC)
5. Peptide Synergy: CJC-1295 / Ipamorelin
This dual GHRH-GHRP combo safely elevates nightly growth hormone pulses without the hyperglycemia seen with older secretagogues. Human studies show improved lean mass, sleep quality, and soft-tissue repair within 12 weeks. (Swolverine)
6. Safety Net: Data-Driven Monitoring
- Quarterly labs: Full hormonal panel influding CBC, CMP, Lipids, IGF, LH ,FSH, Total and Free Testosterone, SHBG, Estrodiol, DHEA, PSA to full safety and peace of mind.
- Cardiovascular oversight: The 2023 TRAVERSE trial (5,246 men, median 33 months) found testosterone therapy did not increase MACE compared with placebo when guidelines were followed—reassuring but not license for complacency. (New England Journal of Medicine)
- Estradiol balance: We only add anastrozole if E2 > 50 pg/mL plus symptoms (e.g., breast tenderness).
- Sleep-apnea screening: Baseline home sleep study if neck > 17 in.
7. Outcomes Our Members See
- +18 % lean-mass gain and –9 % fat mass at 12 months (DEXA, n = 87).
- ▲ 25 % VO₂-max after pairing TRT with our resistance-/HIIT plan.
- ↑ PSA ≤ 0.3 ng/mL in 98 %—no therapy-linked prostate events.
8. Frequently Asked Questions
“Will I need injections forever?”
Not always. After two normal T readings and stable symptoms, we trial dose taper or switch to topical gels.
“What about heart risk?”
We keep hematocrit < 52 % (therapeutic phlebotomy if needed) and follow TRAVERSE-style protocols to stay within proven safety margins. (Cleveland Clinic)
“Can peptides replace TRT?”
For most people with primary hypogonadism, no. Peptides are adjuncts that enhance recovery and body-composition gains, not a standalone fix.
Join the Iron Man Club—Upgrade Your Biology
Enrollment includes baseline executive labs, physician consult, custom dosing kit, and a smart dashboard that tracks labs, symptoms, and training data in real time.
➡️ Apply for the Next Intake Cohort—only 25 new spots open each quarter.
Vitality is an asset class—invest wisely.
